Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Gossamer Bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 120 | −39 |
| Shares | 85.2M | 15.1K | 103.8M | +18.6M (+21.8%) |
| Value | $1.02B | $181.0K | $225.1M | −$795.5M (−77.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 1,453,740 | $3.15M | 0.02% |
| Prosight Management, LP | 265,000 | $575.0K | 0.32% |
| Engineers Gate Manager LP | 243,848 | $529.1K | 0.03% |
| CI Private Wealth, LLC | 168,720 | $366.1K | 0.00% |
| Two Sigma Securities, LLC | 109,084 | $236.7K | 0.03% |
| Jefferies Financial Group Inc. | 100,000 | $217.0K | 0.00% |
| Silverarc Capital Management, LLC | 100,000 | $217.0K | 0.07% |
| Aquatic Capital Management LLC | 46,500 | $101.0K | 0.01% |
| TD Asset Management Inc | 33,800 | $73.3K | 0.00% |
| Walleye Capital LLC | 18,267 | $39.6K | 0.00% |
| Axq Capital, LP | 16,372 | $35.5K | 0.02% |
| AQR Capital Management LLC | 14,473 | $31.4K | 0.00% |
| Atom Investors LP | 12,808 | $27.8K | 0.01% |
| Pictet Asset Management SA | 10,083 | $22.0K | 0.00% |
| Texas Yale Capital Corp. | 10,000 | $21.7K | 0.00% |
| Parallax Volatility Advisers, L.P. | 5,642 | $12.2K | 0.00% |
| Belpointe Asset Management LLC | 4,000 | $8.68K | 0.00% |
| GWM Advisors LLC | 145 | $315 | 0.00% |
| Cary Street Partner Investment Advisory LLC | 100 | $217 | 0.00% |
| Advisory Services Network, LLC | 40 | $87 | 0.00% |
| Covestor Ltd | 10 | $0 | 0.00% |
Sold out (60)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (1)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Dowling & Yahnke LLC | 15,100 | $181.0K |